
Process Validation in Manufacturing of Biopharmaceuticals
CRC Press
3rd Edition
Published on 9. May 2012
Book
Hardback
532 pages
978-1-4398-5093-0 (ISBN)
Article exhausted; check for reprint
Description
Process Validation in Manufacturing of Biopharmaceuticals, Third Edition delves into the key aspects and current practices of process validation. It includes discussion on the final version of the FDA 2011 Guidance for Industry on Process Validation Principles and Practices, commonly referred to as the Process Validation Guidance or PVG, issued in final form on January 24, 2011. The book also provides guidelines and current practices, as well as industrial case studies illustrating the different approaches that can be taken for successful validation of biopharmaceutical processes.
Case studies include
Process validation for membrane chromatography
Leveraging multivariate analysis tools to qualify scale-down models
A matrix approach for process validation of a multivalent bacterial vaccine
Purification validation for a therapeutic monoclonal antibody expressed and secreted by Chinese Hamster Ovary (CHO) cells
Viral clearance validation studies for a product produced in a human cell line
A much-needed resource, this book presents process characterization techniques for scaling down unit operations in biopharmaceutical manufacturing, including chromatography, chemical modification reactions, ultrafiltration, and microfiltration. It also provides practical methods to test raw materials and in-process samples. Stressing the importance of taking a risk-based approach towards computerized system compliance, this book will help you and your team ascertain process validation is carried out and exceeds expectations.
Case studies include
Process validation for membrane chromatography
Leveraging multivariate analysis tools to qualify scale-down models
A matrix approach for process validation of a multivalent bacterial vaccine
Purification validation for a therapeutic monoclonal antibody expressed and secreted by Chinese Hamster Ovary (CHO) cells
Viral clearance validation studies for a product produced in a human cell line
A much-needed resource, this book presents process characterization techniques for scaling down unit operations in biopharmaceutical manufacturing, including chromatography, chemical modification reactions, ultrafiltration, and microfiltration. It also provides practical methods to test raw materials and in-process samples. Stressing the importance of taking a risk-based approach towards computerized system compliance, this book will help you and your team ascertain process validation is carried out and exceeds expectations.
More details
Series
Edition
3rd edition
Language
English
Place of publication
Bosa Roca
United States
Publishing group
Taylor & Francis Inc
Target group
College/higher education
Professional and scholarly
Professional Practice & Development
Product notice
sewn/stitched
Cloth over boards
Illustrations
79 s/w Abbildungen, 82 s/w Tabellen
82 Tables, black and white; 79 Illustrations, black and white
Dimensions
Height: 238 mm
Width: 161 mm
Thickness: 35 mm
Weight
887 gr
ISBN-13
978-1-4398-5093-0 (9781439850930)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
New editions

Anurag Singh Rathore | Hal Baseman | Scott Rudge
Process Validation in Manufacturing of Biopharmaceuticals
Book
12/2023
4th Edition
CRC Press
€250.80
Shipment within 15-20 days
Persons
ANURAG S. RATHORE is a consultant of Biotech CMC Issues. He is also a faculty at the Department of Chemical Engineering, Indian Institute of Technology, Delhi, India. His previous roles included management positions at Amgen Inc., Thousand Oaks, California and Pharmacia Corp., St. Louis, Missouri. His areas of interest include process development, scale-up, technology transfer, process validation, process analytical technology and quality by design. He has authored more than 180 publications and presentations in these areas. He is presently serving as the Editor-in-Chief of Preparative Biochemistry and Biotechnology and serves on the Editorial Advisory Boards for Biotechnology Progress, BioPharm International, Pharmaceutical Technology Europe and Separation and Purification Reviews. Dr. Rathore has edited books titled Quality by Design for Biopharmaceuticals: Perspectives and Case Studies (2009), Elements of Biopharmaceutical Production (2007), Process Validation (2005), Electrokinetic Phenomena (2004) and Scale-up and Optimization in Preparative Chromatography (2003). He has a Ph.D. in Chemical Engineering from Yale University.
Gail Sofer: After serving as the director of Regulatory Services at BioReliance for 6 years, Dr. Sofer has recently joined GE Healthcare (formerly Amersham Biosciences) as the director of Regulatory Compliance in a new consulting team. Her publications include numerous articles and book chapters on downstream processing, virus inactivation, and validation. She has also coedited and authored several books. She serves on the Science Advisory Board of PDA, the Editorial Advisory Boards of BioPharm, BioQuality, and BioProcess International, and the Scale-Up Advisory Board of Genetic Engineering News. She chairs a PDA task force on virus filters and is cochair of the ASTM subcommittee on Adventitious Agents for Tissue Engineered Medical Products. She holds an M.S. degree in biochemistry from the University of Miami.
Gail Sofer: After serving as the director of Regulatory Services at BioReliance for 6 years, Dr. Sofer has recently joined GE Healthcare (formerly Amersham Biosciences) as the director of Regulatory Compliance in a new consulting team. Her publications include numerous articles and book chapters on downstream processing, virus inactivation, and validation. She has also coedited and authored several books. She serves on the Science Advisory Board of PDA, the Editorial Advisory Boards of BioPharm, BioQuality, and BioProcess International, and the Scale-Up Advisory Board of Genetic Engineering News. She chairs a PDA task force on virus filters and is cochair of the ASTM subcommittee on Adventitious Agents for Tissue Engineered Medical Products. She holds an M.S. degree in biochemistry from the University of Miami.
Editor
Bioreliance, Inc. , Warren, New Jersey, USA
Content
Guidelines to Process Validation. Commentary on the US Food and Drug Administration's 2011 "Guidance for Industry, Process Validation General Principles and Practices". Applications of Failure Modes and Effects Analysis to Biotechnology Manufacturing Processes. Process Characterization. Scale-Down Models for Purification Processes: Approaches and Applications. Adventitious Agents: Concerns and Testing for Biopharmaceuticals. Lifespan Studies for Chromatography and Filtration Media. Validation of a Filtration Step. Analytical Test Methods for Well-Characterized Biological and Biotechnological Products. Facility Design Issues: A Regulatory Perspective. Validation of Computerized Systems. Process Validation with a CMO. Risk Management & Validation. Process Validation in Membrane Chromatography. Leveraging Multivariate Analysis Tools to Qualify Scaled-Down Models. Process Validation of a Multivalent Bacterial Vaccine: A Novel Matrix Approach. Validation of the Zevalin (R) Purification Process: A Case Study. Viral Clearance Validation: A Case Study.